3.55MMarket Cap-736P/E (TTM)
0.4115High0.3300Low3.02MVolume0.4040Open0.4115Pre Close1.15MTurnover34.17%Turnover RatioLossP/E (Static)8.92MShares2.080052wk High0.32P/B3.51MFloat Cap0.120752wk Low--Dividend TTM8.84MShs Float160.5000Historical High--Div YieldTTM19.81%Amplitude0.1207Historical Low0.3810Avg Price1Lot Size
InMed Pharmaceuticals Stock Forum
In recent years, the race to find effective treatments for Alzheimer's disease has intensified, driven by the rising prevalence of the condition and the challenges it poses to patients, caregivers, and healthcare systems worldwide. In this context, InMed Pharmaceuticals Inc., a company known for its innovative approaches to dr...
newsfile· 6 mins ago
InMed's intellectual property portfolio totals 13 patent families covering new chemical entities, formulations, manufacturing methods and methods of use
Vancouver, British Columbia--(Newsfile Corp. - August 21, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprie...
No comment yet